Literature DB >> 20707936

Induced pluripotent stem cells--alchemist's tale or clinical reality?

S Tamir Rashid1, Ludovic Vallier.   

Abstract

Following Shinya Yamanaka's first report describing the reprogramming of fibroblasts into stem cells over three years ago, some sceptics initially drew analogies between this new field of research and the quasi-mystical practice of 'alchemy'. Unlike the alchemist, however, stem cell researchers have rigorously tested and repeated experiments, proving their very own brand of cellular 'alchemy' to be a reality, with potentially massive implications for the study of human biology and clinical medicine. These investigations have resulted in an explosion of related publications and initiated the field of stem cell research known as 'induced pluripotency'. In this review, we give an account of the historical development, current technologies and potential clinical applications of induced pluripotency and conclude with a perspective on the possible future directions for this dynamic field.

Entities:  

Mesh:

Year:  2010        PMID: 20707936     DOI: 10.1017/S1462399410001596

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  7 in total

1.  Stem cell therapeutics--reality versus hype and hope.

Authors:  Nicolas H Zech; Karl-Heinz Preisegger; Peter Hollands
Journal:  J Assist Reprod Genet       Date:  2010-12-08       Impact factor: 3.412

Review 2.  Lineage conversion methodologies meet the reprogramming toolbox.

Authors:  Ignacio Sancho-Martinez; Sung Hee Baek; Juan Carlos Izpisua Belmonte
Journal:  Nat Cell Biol       Date:  2012-09       Impact factor: 28.824

3.  Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis.

Authors:  Derek J Langeslay; Consuelo N Beecher; Annamaria Naggi; Marco Guerrini; Giangiacomo Torri; Cynthia K Larive
Journal:  Anal Chem       Date:  2012-12-31       Impact factor: 6.986

4.  Patient-specific pluripotent stem cells in neurological diseases.

Authors:  Serpen Durnaoglu; Sermin Genc; Kursad Genc
Journal:  Stem Cells Int       Date:  2011-07-03       Impact factor: 5.443

5.  Production of hepatocyte-like cells from human pluripotent stem cells.

Authors:  Nicholas R F Hannan; Charis-Patricia Segeritz; Thomas Touboul; Ludovic Vallier
Journal:  Nat Protoc       Date:  2013-02       Impact factor: 13.491

6.  Human embryonic mesenchymal stem cells participate in differentiation of renal tubular cells in newborn mice.

Authors:  Li Yuan; Hou-Qi Liu; Min-Juan Wu
Journal:  Exp Ther Med       Date:  2016-05-24       Impact factor: 2.447

7.  Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell-Derived Hepatocytes for Cell-Based Therapy.

Authors:  Samuel J I Blackford; Soon Seng Ng; Joe M Segal; Aileen J F King; Amazon L Austin; Deniz Kent; Jennifer Moore; Michael Sheldon; Dusko Ilic; Anil Dhawan; Ragai R Mitry; S Tamir Rashid
Journal:  Stem Cells Transl Med       Date:  2018-11-19       Impact factor: 6.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.